Related Experiment Video
Updated: Apr 19, 2026
09:55
Bridging the Technology Divide in the COVID-19 Era: Using Virtual Outreach to Expose Middle and High School Students to Imaging Technology
Published on: September 28, 2022
2.4K
[Virtual paediatric medicine].
1Diabeter, Nationaal behandelcentrum voor diabetes bij kinderen en jongeren, Rotterdam.
Nederlands Tijdschrift Voor Geneeskunde
|December 18, 2014
Summary
Health information technology improves care for children with chronic diseases like diabetes. Direct patient feedback on glucose levels enhances outcomes, but data access remains a challenge.
Area of Science:
- Medical Informatics
- Pediatric Endocrinology
Background:
- Health information technology (eHealth) offers cost-effective care solutions by replacing traditional services.
- eHealth can significantly support and enhance care for pediatric chronic conditions.
Purpose of the Study:
- To demonstrate the benefits of eHealth in managing chronic diseases in children.
- To highlight the positive impact of direct patient feedback on glucose levels in pediatric diabetes care.
Main Methods:
- Utilizing health information technology to provide direct patient feedback.
- Leveraging electronic patient files for data access and utilization.
Main Results:
- Direct feedback on glucose levels leads to improved patient care outcomes.
- Effective data access from electronic patient files is currently limited in many institutions.
Conclusions:
- eHealth, particularly through direct patient feedback, shows promise for improving pediatric chronic disease management.
- Challenges in accessing and utilizing electronic health data hinder the full potential of eHealth implementation.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
392
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
392
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
373
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
895
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
895
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
513
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
513
01:25Transmission-based Precautions II: Airborne and Protective Environment
2.2K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.2K
01:29Drug Dosing: Infants and Children
935
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
935